Isoquinoline and benzo[H]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine H3 receptor

Details for Australian Patent Application No. 2006316706 (hide)

Owner Sanofi Aventis

Inventors Escribano Arenales, Beatriz; Jimenez Bargueno, Maria Dolores; Diaz Martin, Juan Antonio

Agent A J Park

Pub. Number AU-B-2006316706

PCT Pub. Number WO2007/060027

Priority 05111248.0 24.11.05 EP

Filing date 22 November 2006

Wipo publication date 31 May 2007

Acceptance publication date 3 May 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4725 (2006.01)

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/060027 Priority application(s): WO2007/060027

3 May 2012 Application Accepted

  Published as AU-B-2006316706

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316717-Preparation, comprising iron(III) complex compounds and redox-active substances

2006316705-Urea derivatives useful as calcium receptor modulators